Chikungunya vaccine trial for kids halted before start
NCT ID NCT07133178
First seen Sep 30, 2025 · Last updated May 16, 2026 · Updated 34 times
Summary
This study was designed to test a vaccine called VLA1553 to prevent chikungunya virus infection in healthy children aged 1 to 11 years. The trial planned to enroll over 3,000 children and compare the vaccine to a standard shot. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.